DCGI approves clinical trials of Biological E. Covid-19 vaccine CORBEVAX on children
The Hindu
It has also received nod for conducting Phase III trial in adults
Hyderabad-based pharmaceutical firm Biological E. has for initiating the Phase II/III study to evaluate its CORBEVAX vaccine in children aged above 5 years. It has also received nod for conducting Phase III trial in adults after a Subject Expert Committee’s (SEC) review of its Phase I and II clinical trials data, a PIB release stated on September 3. Supported by the Department of Biotechnology, Biological E. has developed CORBEVAX, a RBD protein sub-unit vaccine for coronavirus disease.
The Central Committee of the Communist Party of India (Marxist) on Friday pledged to mobilise people in resistance against the BJP-led Union government’s “anti-agricultural worker, anti-farmer, anti-worker, anti-people” laws and policies till they are all repealed, the party said on Friday. In a statement issued here, the CPI(M) said the members took the pledge following a three-day meeting held at Thiruvananthapuram.

Expressing the need for more number of socially responsive engineers and lawyers for furthering development of the country, Governor Thaawarchad Gehlot here on Friday lauded St. Aloysius institution for widening its service in the education sector by opening separate institutes for engineering and law











